-
EP1669446
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP1669446
| EP1669446 - SCREENING METHOD [Right-click to bookmark this link] | Status | The application is deemed to be withdrawn Status updated on 26.06.2009 Database last updated on 28.03.2026 | Most recent event Tooltip | 26.06.2009 | Application deemed to be withdrawn | published on 29.07.2009 [2009/31] | Applicant(s) | For all designated states Takeda Pharmaceutical Company Limited 1-1, Doshomachi 4-chome Chuo-ku Osaka-shi Osaka 541-0045 / JP | [2006/24] | Inventor(s) | 01 /
HAYASHI, Ryogo 4-14, Asahigaoka 1-chome Ikeda-shi, Osaka 5630022 / JP | 02 /
IIZAWA, Yuji 31-20, Dencho, Teradocho Muko-shi, Kyoto 6170002 / JP | [2006/24] | Representative(s) | Lewin, John Harvey TGRD (Europe) Intellectual Property Department 61 Aldwych London WC2B 4AE / GB | [N/P] |
| Former [2006/24] | Lewin, John Harvey Takeda Euro IP Department 10 Charles II Street London SW1Y 4AA / GB | Application number, filing date | 04773069.2 | 08.09.2004 | [2006/24] | WO2004JP13396 | Priority number, date | JP20030316572 | 09.09.2003 Original published format: JP 2003316572 | [2006/24] | Filing language | JA | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2005026348 | Date: | 24.03.2005 | Language: | EN | [2005/12] | Type: | A1 Application with search report | No.: | EP1669446 | Date: | 14.06.2006 | Language: | EN | The application published by WIPO in one of the EPO official languages on 24.03.2005 takes the place of the publication of the European patent application. | [2006/24] | Search report(s) | International search report - published on: | JP | 24.03.2005 | (Supplementary) European search report - dispatched on: | EP | 13.06.2008 | Classification | IPC: | C12N15/09, C12Q1/02, C12Q1/68, G01N33/15, G01N33/50, A61P9/10 | [2006/24] | CPC: |
G01N33/6893 (EP,US);
A61P9/10 (EP);
G01N33/56927 (EP,US);
G01N2500/00 (EP,US);
G01N2800/323 (EP,US)
| Designated contracting states | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IT, LI, LU, MC, NL, PL, PT, RO, SE, SI, SK, TR [2006/24] | Extension states | AL | Not yet paid | HR | Not yet paid | LT | Not yet paid | LV | Not yet paid | MK | Not yet paid | Title | German: | SCREENING-VERFAHREN | [2006/24] | English: | SCREENING METHOD | [2006/24] | French: | METHODE DE CRIBLAGE | [2006/24] | Biological material | This application mentions deposited biological material, check the file for details | Entry into regional phase | 08.03.2006 | Translation filed | 08.03.2006 | National basic fee paid | 08.03.2006 | Search fee paid | 08.03.2006 | Designation fee(s) paid | 08.03.2006 | Examination fee paid | Examination procedure | 08.03.2006 | Amendment by applicant (claims and/or description) | 08.03.2006 | Examination requested [2006/24] | 25.09.2008 | Despatch of a communication from the examining division (Time limit: M04) | 06.02.2009 | Application deemed to be withdrawn, date of legal effect [2009/31] | 12.03.2009 | Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time [2009/31] | Fees paid | Renewal fee | 08.03.2006 | Renewal fee patent year 03 | 12.09.2007 | Renewal fee patent year 04 | 15.09.2008 | Renewal fee patent year 05 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [T] SCHMIDT ROLAND ET AL: "EMMPRIN (CID 147) is a central activator of extracellular matrix degradation by Chlamydia pneumoniae-infected monocytes. Implications for plaque rupture", THROMBOSIS AND HAEMOSTASIS, vol. 95, no. 1, January 2006 (2006-01-01), pages 151 - 158, XP002481603, ISSN: 0340-6245 [T] | International search | [Y] KOL A. ET AL.: "Chlamydial heat shock protein 60 localizes in human atheroma and regulates macrophage tumor necrosis factor-alpha and matrix metalloproteinase expression", CIRCULATION, vol. 98, no. 4, 1998, pages 300 - 307, XP002904144 [Y] | [Y] VEHMAAN-KREULA P. ET AL.: "Chlamydia pneumoniae proteins induce secretion of the 92-kDa gelatinase by human monocytederived macrophages", ARTERIOSCLER THROMB VASC. BIOL., vol. 21, no. 1, 2001, pages 1 - 8, XP002904145 [Y] | [Y] SHIRAI M. ET AL.: "Comparison of the whole genome sequences of chlamydia pneumoniae J138 from Japan and CWL029 from USA", NUCLEIC ACIDS RES, vol. 28, no. 12, 2000, pages 2311 - 2314, XP002166059 [Y] DOI: http://dx.doi.org/10.1093/nar/28.12.2311 | [A] LOFTUS I.M. ET AL.: "Increased matrix metalloproteinase-9 activity in unstable carotid plagues. A potential role in acute plague disruption", STROKE, vol. 31, no. 1, 2000, pages 40 - 47, XP002173383 [A] | [A] BLANKENBERG S. ET AL.: "Plasma concentrations and genetic variation of matrix metalloproteinase 9 and prognosis of patients with cardiovascular disease", CIRCULATION, vol. 107, no. 12, April 2003 (2003-04-01), pages 1579 - 1585, XP002904146 [A] DOI: http://dx.doi.org/10.1161/01.CIR.0000058700.41738.12 |